admin
President Trump’s White House has published a new U.S. government policy that makes one thing plain: the federal government will not bankroll the most dangerous kinds of gain-of-function research. The move is short, sharp, and should make taxpayers breathe easier — at least until the rulebooks get shuffled and the lawyers get busy.
White House moves to stop dangerous gain-of-function research
The new policy, billed as the “United States Government Policy for Stopping High‑Risk Life Sciences Research,” says dangerous gain-of-function (DGOF) work will not receive federal funding. It builds on the President’s earlier executive action and gives a formal, government-wide definition of the highest-risk experiments. In plain language: if a project could make a pathogen more harmful or easier to spread, federal dollars are now off-limits.
What the policy bans and how it works
This is not a one-line ban and walk away. The policy sets up a risk-based system. Colleges and labs that want federal money must create Institutional Review Entities (IREs) to vet risky projects. A centralized Independent Third-Party Review Body (ITPRB) will review flagged proposals and report on compliance. The policy also tightens rules on international collaborations, blocking funding for work with entities or in countries that do not meet U.S. biosafety and biosecurity standards. Agencies have a deadline to write implementation guidance and will have tools like audits, funding conditions, and debarment to enforce the rules.
Why this matters to taxpayers and national security
This is an America First approach to science funding. Taxpayer money should not underwrite experiments that could spark a pandemic or hand a security advantage to hostile actors. Conservatives who warned about risky research and about foreign labs getting advanced help have been vindicated. Yes, basic science matters. Yes, vaccines and countermeasures must keep advancing. But those ends do not justify careless experiments that increase the odds of disaster. If you want smart science, you should want strict oversight.
What to watch next — keep the pressure on
The policy is a clear signal, but the work is only beginning. Watch for agency implementation guidance, the names and rules for IRE and ITPRB members, and any immediate changes to grants and collaborations. The scientific establishment will lobby hard for carve-outs and vague exemptions. That’s expected. Conservatives must insist on transparency, quick audits, and real penalties if institutions cut corners. This policy is a real victory for common sense — now the administration must make it stick and not let bureaucracy or backroom deals water it down.
